AVTE |
Aerovate Therapeutics, Inc. |
Feb 5, 2024 |
8 |
-$71K |
4 |
Feb 7, 2024 |
CHIEF SCIENTIFIC OFFICER |
AVTE |
Aerovate Therapeutics, Inc. |
Jan 22, 2024 |
1 |
$0 |
4 |
Jan 24, 2024 |
CHIEF SCIENTIFIC OFFICER |
AVTE |
Aerovate Therapeutics, Inc. |
Jan 5, 2024 |
9 |
-$78.8K |
4 |
Jan 8, 2024 |
CHIEF SCIENTIFIC OFFICER |
AVTE |
Aerovate Therapeutics, Inc. |
Dec 5, 2023 |
8 |
-$65.7K |
4 |
Dec 7, 2023 |
CHIEF SCIENTIFIC OFFICER |
AVTE |
Aerovate Therapeutics, Inc. |
Nov 22, 2023 |
8 |
-$179K |
4 |
Nov 27, 2023 |
CHIEF SCIENTIFIC OFFICER |
AVTE |
Aerovate Therapeutics, Inc. |
Jul 5, 2023 |
9 |
-$34.4K |
4 |
Jul 7, 2023 |
CHIEF SCIENTIFIC OFFICER |
AVTE |
Aerovate Therapeutics, Inc. |
Jun 5, 2023 |
8 |
-$32K |
4 |
Jun 7, 2023 |
CHIEF SCIENTIFIC OFFICER |
AVTE |
Aerovate Therapeutics, Inc. |
May 5, 2023 |
9 |
-$42.4K |
4 |
May 9, 2023 |
CHIEF SCIENTIFIC OFFICER |
AVTE |
Aerovate Therapeutics, Inc. |
Apr 5, 2023 |
9 |
-$36.4K |
4 |
Apr 7, 2023 |
CHIEF SCIENTIFIC OFFICER |
AVTE |
Aerovate Therapeutics, Inc. |
Mar 6, 2023 |
9 |
-$48.9K |
4 |
Mar 8, 2023 |
CHIEF SCIENTIFIC OFFICER |
AVTE |
Aerovate Therapeutics, Inc. |
Feb 6, 2023 |
9 |
-$50.1K |
4 |
Feb 8, 2023 |
CHIEF SCIENTIFIC OFFICER |
AVTE |
Aerovate Therapeutics, Inc. |
Jan 5, 2023 |
8 |
-$54.8K |
4 |
Jan 9, 2023 |
CHIEF SCIENTIFIC OFFICER |
AVTE |
Aerovate Therapeutics, Inc. |
Dec 5, 2022 |
8 |
-$34.6K |
4 |
Dec 7, 2022 |
CHIEF SCIENTIFIC OFFICER |
AVTE |
Aerovate Therapeutics, Inc. |
Nov 7, 2022 |
11 |
-$38.6K |
4 |
Nov 9, 2022 |
CHIEF SCIENTIFIC OFFICER |
AVTE |
Aerovate Therapeutics, Inc. |
Oct 5, 2022 |
9 |
-$30.9K |
4 |
Oct 7, 2022 |
CHIEF SCIENTIFIC OFFICER |
AVTE |
Aerovate Therapeutics, Inc. |
Sep 6, 2022 |
8 |
-$38.2K |
4 |
Sep 7, 2022 |
Chief Scientific Officer |
AVTE |
Aerovate Therapeutics, Inc. |
Aug 18, 2022 |
8 |
-$43.1K |
4 |
Aug 19, 2022 |
Chief Scientific Officer |
AVTE |
Aerovate Therapeutics, Inc. |
Dec 14, 2021 |
1 |
$0 |
4 |
Dec 16, 2021 |
Chief Development Officer |
AVTE |
Aerovate Therapeutics, Inc. |
Jun 29, 2021 |
0 |
$0 |
3 |
Jun 29, 2021 |
Chief Development Officer |
AVTE |
Aerovate Therapeutics, Inc. |
Apr 2, 2021 |
3 |
$0 |
4 |
Jul 1, 2021 |
Chief Development Officer |